PERCEVAL ™

First Patient Enrolled in the PERSIST-AVR Trial at CHU Brabois, University of Lorraine, Nancy – France

Discover more

MEMO 3D RECHORD

LivaNova receives regulatory approval in Canada for its innovative Memo 3D ReChord annuloplasty ring for mitral valve repair

Discover more

PERCEVAL

LivaNova announces the first U.S. implant of Perceval, the only sutureless valve for aortic valve replacement surgery

Discover more

SOLO SMART

LivaNova receives regulatory approval in Japan for the Solo Smart stentless tissue aortic valve

Discover more

CROWN PRT ™

LivaNova announces FDA approval of stented heart valve CROWN PRT ™ for aortic valve disease

Discover more

KORA 250 now approved in Japan

World’s smallest full body MRI conditional pacing system with extended longevity and proprietary technologies designed to improve patient outcome

Discover more

Latest News

Aug 28, 2016

SonR™: Long Term Clinical Update Confirms Risk Reduction in Heart Failure Hospitalization

READ MORE

Aug 11, 2016

LivaNova PLC to Present at the Morgan Stanley Global Healthcare Conference

READ MORE

Aug 3, 2016

LivaNova Reports Second Quarter 2016 Results

READ MORE

Aug 1, 2016

LivaNova PLC Names Chief Operating Officer

READ MORE

Jul 28, 2016

LivaNova PLC Names Andrea L. Saia to its Board of Directors

READ MORE

In the Spotlight

Version unknown | Revision 92986 | Status unstable | SessionId FD6F4E5D7B35459C529ED9CD9D1B15D4.jvm1